Phospholipid Market by Source, Form, and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030

Table of Contents

CHAPTER 1: INTRODUCTION1.1. Key benefits for stakeholders
1.2. Key market segments
1.3. Research methodology
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Value chain analysis
3.4. Porter’s five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Growing Demand for Naturally Sourced Ingredients
3.5.1.2. Increasing Demand for Phospholipid in the Pharmaceutical and Cosmetics Industries
3.5.2. Restraints
3.5.2.1. Genetically modified foods may act as a threat to the environment
3.5.3. Opportunities
3.5.3.1. Growing Demand for Alternate Sources of Phospholipid
3.5.3.2. Increase in demand for label-friendly products among consumers
3.6. Market share analysis
3.6.1. By source
3.6.2. By form
3.6.3. By application
3.6.4. By region
3.7. Parent/Peer Analysis
3.8. Impact of COVID-19 on the phospholipid market

CHAPTER 4: PHOSPHOLIPID MARKET, BY SOURCE4.1. Overview
4.1.1. Market size and forecast
4.2. Soy
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Egg
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Others
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

CHAPTER 5: PHOSPHOLIPID MARKET, FORM5.1. Overview
5.1.1. Market size and forecast
5.2. Powder
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.4. Granule
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country

CHAPTER 6: PHOSPHOLIPID MARKET, APPLICATION6.1. Overview
6.1.1. Market size and forecast
6.2. Nutrition & supplements
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. Pharmaceuticals
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. Others
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country

CHAPTER 7: PHOSPHOLIPID MARKET, BY REGION7.1. Overview
7.1.1. Market size and forecast, by region
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by source
7.2.3. Market size and forecast, by form
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by source
7.2.5.1.2. Market size and forecast, by form
7.2.5.1.3. Market size and forecast, by application
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by source
7.2.5.2.2. Market size and forecast, by form
7.2.5.2.3. Market size and forecast, by application
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by source
7.2.5.3.2. Market size and forecast, by form
7.2.5.3.3. Market size and forecast, by application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by source
7.3.3. Market size and forecast, by form
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by source
7.3.5.1.2. Market size and forecast, by form
7.3.5.1.3. Market size and forecast, by application
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by source
7.3.5.2.2. Market size and forecast, by form
7.3.5.2.3. Market size and forecast, by application
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by source
7.3.5.3.2. Market size and forecast, by form
7.3.5.3.3. Market size and forecast, by application
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by source
7.3.5.4.2. Market size and forecast, by form
7.3.5.4.3. Market size and forecast, by application
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by source
7.3.5.5.2. Market size and forecast, by form
7.3.5.5.3. Market size and forecast, by application
7.3.5.6. Russia
7.3.5.6.1. Market size and forecast, by source
7.3.5.6.2. Market size and forecast, by form
7.3.5.6.3. Market size and forecast, by application
7.3.5.7. Rest of Europe
7.3.5.7.1. Market size and forecast, by source
7.3.5.7.2. Market size and forecast, by form
7.3.5.7.3. Market size and forecast, by application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by source
7.4.3. Market size and forecast, by form
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by source
7.4.5.1.2. Market size and forecast, by form
7.4.5.1.3. Market size and forecast, by application
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by source
7.4.5.2.2. Market size and forecast, by form
7.4.5.2.3. Market size and forecast, by application
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by source
7.4.5.3.2. Market size and forecast, by form
7.4.5.3.3. Market size and forecast, by application
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by source
7.4.5.4.2. Market size and forecast, by form
7.4.5.4.3. Market size and forecast, by application
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by source
7.4.5.5.2. Market size and forecast, by form
7.4.5.5.3. Market size and forecast, by application
7.4.5.6. Thailand
7.4.5.6.1. Market size and forecast, by source
7.4.5.6.2. Market size and forecast, by form
7.4.5.6.3. Market size and forecast, by application
7.4.5.7. Singapore
7.4.5.7.1. Market size and forecast, by source
7.4.5.7.2. Market size and forecast, by form
7.4.5.7.3. Market size and forecast, by application
7.4.5.8. Rest of Asia-Pacific
7.4.5.8.1. Market size and forecast, by source
7.4.5.8.2. Market size and forecast, by form
7.4.5.8.3. Market size and forecast, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by source
7.5.3. Market size and forecast, by form
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by source
7.5.5.1.2. Market size and forecast, by form
7.5.5.1.3. Market size and forecast, by application
7.5.5.2. Argentina
7.5.5.2.1. Market size and forecast, by source
7.5.5.2.2. Market size and forecast, by form
7.5.5.2.3. Market size and forecast, by application
7.5.5.3. UAE
7.5.5.3.1. Market size and forecast, by source
7.5.5.3.2. Market size and forecast, by form
7.5.5.3.3. Market size and forecast, by application
7.5.5.4. Nigeria
7.5.5.4.1. Market size and forecast, by source
7.5.5.4.2. Market size and forecast, by form
7.5.5.4.3. Market size and forecast, by application
7.5.5.5. South Africa
7.5.5.5.1. Market size and forecast, by source
7.5.5.5.2. Market size and forecast, by form
7.5.5.5.3. Market size and forecast, by application
7.5.5.6. Turkey
7.5.5.6.1. Market size and forecast, by source
7.5.5.6.2. Market size and forecast, by form
7.5.5.6.3. Market size and forecast, by application
7.5.5.7. Rest of LAMEA
7.5.5.7.1. Market size and forecast, by source
7.5.5.7.2. Market size and forecast, by form
7.5.5.7.3. Market size and forecast, by application

CHAPTER 8: COMPETITION LANDSCAPE8.1. Top winning strategies
8.2. Product mapping
8.3. Competitive dashboard
8.4. Competitive heat map
8.5. Key developments
8.5.1. Acquisition
8.5.2. Business Expansion
8.5.3. Product Launch

CHAPTER 9: COMPANY PROFILES9.1. ARCHER-DANIELS-MIDLAND COMPANY
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Bunge Ltd.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Cargill, Incorporated
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. DuPont de Nemours, Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. R&D expenditure
9.4.7. Business performance
9.4.8. Key strategic moves and developments
9.5. Kewpie Corporation
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. R&D Expenditure
9.5.7. Business performance
9.6. Lasenor Emul SL
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments
9.7. Lipoid GmbH
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Product portfolio
9.8. SojaProtein a. d
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Product portfolio
9.9. VAV Life Sciences Pvt. Ltd.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Product portfolio
9.9.5. Key strategic moves and developments
9.10. Wilmar International Ltd.
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance

List of Tables

TABLE 01. PHOSPHOLIPID MARKET REVENUE, BY SOURCE, 2020-2030 ($MILLION)
TABLE 02. SOY PHOSPHOLIPID MARKET REVENUE, BY REGION, 2020-2030 ($MILLION)
TABLE 03. EGG PHOSPHOLIPID MARKET REVENUE, BY REGION 2020-2030 ($MILLION)
TABLE 04. OTHER PHOSPHOLIPID MARKET REVENUE, BY REGION 2020-2030 ($MILLION)
TABLE 05. PHOSPHOLIPID MARKET REVENUE, BY FORM, 2020-2030($MILLION)
TABLE 06. PHOSPHOLIPID MARKET REVENUE FOR POWDER, BY REGION, 2020-2030 ($MILLION)
TABLE 07. PHOSPHOLIPID MARKET REVENUE FOR GRANULE, BY REGION, 2020-2030 ($MILLION)
TABLE 08. PHOSPHOLIPID MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 09. PHOSPHOLIPID MARKET REVENUE FOR NUTRITION & SUPPLEMENTS, BY REGION, 2020-2030 ($MILLION)
TABLE 10. PHOSPHOLIPID MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2020-2030 ($MILLION)
TABLE 11. PHOSPHOLIPID MARKET REVENUE FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 12. PHOSPHOLIPID MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 13. NORTH AMERICA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 14. NORTH AMERICA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 15. NORTH AMERICA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 16. NORTH AMERICA PHOSPHOLIPID MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 17. U.S. PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 18. U.S. PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 19. U.S. PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 20. CANADA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 21. CANADA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 22. CANADA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 23. MEXICO PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 24. MEXICO PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 25. MEXICO PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 26. EUROPE PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 27. EUROPE PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 28. EUROPE PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 29. EUROPE PHOSPHOLIPID MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 30. GERMANY PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 31. GERMANY PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 32. GERMANY PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 33. FRANCE PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 34. FRANCE PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 35. FRANCE PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 36. UK PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 37. UK PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 38. UK PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 39. ITALY PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 40. ITALY PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 41. ITALY PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 42. SPAIN PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 43. SPAIN PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 44. SPAIN PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 45. RUSSIA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 46. RUSSIA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 47. RUSSIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 48. REST OF EUROPE PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 49. REST OF EUROPE PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 50. REST OF EUROPE PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 51. ASIA-PACIFIC PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 52. ASIA-PACIFIC PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 53. ASIA-PACIFIC PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 54. ASIA-PACIFIC PHOSPHOLIPID MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 55. CHINA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 56. CHINA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 57. CHINA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 58. JAPAN PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 59. JAPAN PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 60. JAPAN PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 61. INDIA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 62. INDIA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 63. INDIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 64. AUSTRALIA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 65. AUSTRALIA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 66. AUSTRALIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 67. SOUTH KOREA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 68. SOUTH KOREA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 69. SOUTH KOREA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 70. THAILAND PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 71. THAILAND PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 72. THAILAND PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 73. SINGAPORE PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 74. SINGAPORE PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 75. SINGAPORE PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 76. REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 77. REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 78. REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 79. LAMEA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 80. LAMEA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 81. LAMEA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 82. LAMEA PHOSPHOLIPID MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 83. BRAZIL PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 84. BRAZIL PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 85. BRAZIL PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 86. ARGENTINA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 87. ARGENTINA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 88. ARGENTINA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 89. UAE PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 90. UAE PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 91. UAE PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 92. NIGERIA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 93. NIGERIA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 94. NIGERIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 95. SOUTH AFRICA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 96. SOUTH AFRICA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 97. SOUTH AFRICA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 98. TURKEY PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 99. TURKEY PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 100. TURKEY PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 101. REST OF LAMEA PHOSPHOLIPID MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 102. REST OF LAMEA PHOSPHOLIPID MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 103. REST OF LAMEA PHOSPHOLIPID MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 104. ARCHER-DANIELS-MIDLAND COMPANY: KEY EXECUTIVES
TABLE 105. ARCHER-DANIELS-MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 106. ARCHER-DANIELS-MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 107. ARCHER-DANIELS-MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 108. ARCHER-DANIELS-MIDLAND COMPANY: NET SALES, 2017-2019 ($MILLION)
TABLE 109. BUNGE LTD.: KEY EXECUTIVES
TABLE 110. BUNGE LTD.: COMPANY SNAPSHOT
TABLE 111. BUNGE LTD.: OPERATING SEGMENTS
TABLE 112. BUNGE LTD.: PRODUCT PORTFOLIO
TABLE 113. BUNGE LTD.: NET SALES, 2018-2020 ($MILLION)
TABLE 114. CARGILL, INCORPORATED: KEY EXECUTIVES
TABLE 115. CARGILL, INCORPORATED: COMPANY SNAPSHOT
TABLE 116. CARGILL, INCORPORATED: OPERATING SEGMENTS
TABLE 117. CARGILL, INCORPORATED: PRODUCT PORTFOLIO
TABLE 118. CARGILL, INCORPORATED: NET SALES, 2018-2020 ($MILLION)
TABLE 119. DUPONT DE NEMOURS, INC.: KEY EXECUTIVES
TABLE 120. DUPONT DE NEMOURS, INC.: COMPANY SNAPSHOT
TABLE 121. DUPONT DE NEMOURS, INC.: OPERATING SEGMENTS
TABLE 122. DUPONT DE NEMOURS, INC.: PRODUCT PORTFOLIO
TABLE 123. DUPONT DE NEMOURS, INC.: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 124. DUPONT DE NEMOURS, INC.: NET SALES, 2018-2020 ($MILLION)
TABLE 125. KEWPIE CORPORATION: KEY EXECUTIVES
TABLE 126. KEWPIE CORPORATION: COMPANY SNAPSHOT
TABLE 127. KEWPIE CORPORATION: OPERATING SEGMENTS
TABLE 128. KEWPIE CORPORATION: PRODUCT PORTFOLIO
TABLE 129. KEWPIE CORPORATION: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 130. KEWPIE CORPORATION: NET SALES, 2018-2020 ($MILLION)
TABLE 131. LASENOR EMUL SL: KEY EXECUTIVES
TABLE 132. LASENOR EMUL SL: COMPANY SNAPSHOT
TABLE 133. LASENOR EMUL SL: PRODUCT PORTFOLIO
TABLE 134. LIPOID GMBH: KEY EXECUTIVES
TABLE 135. LIPOID GMBH: COMPANY SNAPSHOT
TABLE 136. LIPOID GMBH: PRODUCT PORTFOLIO
TABLE 137. SOJAPROTEIN A. D: KEY EXECUTIVES
TABLE 138. SOJAPROTEIN A. D: COMPANY SNAPSHOT
TABLE 139. SOJAPROTEIN A. D: PRODUCT PORTFOLIO
TABLE 140. VAV LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 141. VAV LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 142. VAV LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 143. WILMAR INTERNATIONAL LTD.: KEY EXECUTIVES
TABLE 144. WILMAR INTERNATIONAL LTD.: COMPANY SNAPSHOT
TABLE 145. WILMAR INTERNATIONAL LTD.: OPERATING SEGMENTS
TABLE 146. WILMAR INTERNATIONAL LTD.: PRODUCT PORTFOLIO
TABLE 147. WILMAR INTERNATIONAL LTD.: NET SALES, 2018-2020 ($MILLION)

List of Figures

FIGURE 01. GLOBAL PHOSPHOLIPID MARKET SNAPSHOT
FIGURE 02. GLOBAL PHOSPHOLIPID MARKET: SEGMENTATION
FIGURE 03. TOP IMPACTING FACTORS
FIGURE 04. TOP INVESTMENT POCKETS
FIGURE 05. TOP PLAYERS POSITIONING
FIGURE 06. VALUE CHAIN ANALYSIS
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08. MODERATE BARGAINING POWER OF BUYERS
FIGURE 09. MODERATE THREAT OF SUBSTITUTION
FIGURE 10. MODERATE THREAT OF NEW ENTRANTS
FIGURE 11. MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 12. PHOSPHOLIPID MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13. PARENT/PEER ANALYSIS
FIGURE 14. PHOSPHOLIPID MARKET REVENUE, BY SOURCE, 2020 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF SOY PHOSPHOLIPID MARKET REVENUE, BY COUNTRY, 2020 & 2030(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS FOR EGG PHOSPHOLIPID MARKET REVENUE, BY COUNTRY, 2020 & 2030(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS FOR OTHER PHOSPHOLIPID MARKET REVENUE, BY COUNTRY, 2020 & 2030(%)
FIGURE 18. PHOSPHOLIPID MARKET, BY FORM, 2020 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PHOSPHOLIPID MARKET FOR POWDER, BY COUNTRY, 2020 & 2030(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PHOSPHOLIPID MARKET FOR GRANULE, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21. PHOSPHOLIPID MARKET, BY APPLICATION, 2020 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF PHOSPHOLIPID MARKET FOR NUTRITION & SUPPLEMENTS, BY COUNTRY, 2020 & 2030(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF PHOSPHOLIPID MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF PHOSPHOLIPID MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 25. PHOSPHOLIPID MARKET, BY REGION, 2020 (%)
FIGURE 26. U.S. PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 27. CANADA PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 28. MEXICO PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 29. GERMANY PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 30. FRANCE PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 31. UK PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 32. ITALY PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 33. SPAIN PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 34. RUSSIA PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 35. REST OF EUROPE PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 36. CHINA PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 37. JAPAN PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 38. INDIA PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 39. AUSTRALIA PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 40. SOUTH KOREA PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 41. THAILAND PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 42. SINGAPORE PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 43. REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 44. BRAZIL PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 45. ARGENTINA PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 46. UAE PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 47. NIGERIA PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 48. SOUTH AFRICA PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 49. TURKEY PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 50. REST OF LAMEA PHOSPHOLIPID MARKET, 2020-2030 ($MILLION)
FIGURE 51. TOP WINNING STRATEGIES, BY YEAR, 2017-2019
FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2019 (%)
FIGURE 53. PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 54. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 55. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 56. ARCHER-DANIELS-MIDLAND COMPANY: NET SALES, 2017-2019 ($MILLION)
FIGURE 57. ARCHER-DANIELS-MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 58. ARCHER-DANIELS-MIDLAND COMPANY: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 59. BUNGE LTD.: NET SALES, 2018-2020 ($MILLION)
FIGURE 60. BUNGE LTD.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 61. CARGILL, INCORPORATED: NET SALES, 2018-2020 ($MILLION)
FIGURE 62. DUPONT DE NEMOURS, INC.: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 63. DUPONT DE NEMOURS, INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 64. DUPONT DE NEMOURS, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65. DUPONT DE NEMOURS, INC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 66. KEWPIE CORPORATION: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 67. KEWPIE CORPORATION: NET SALES, 2018-2020 ($MILLION)
FIGURE 68. KEWPIE CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 69. WILMAR INTERNATIONAL LTD.: NET SALES, 2018-2020 ($MILLION)
FIGURE 70. WILMAR INTERNATIONAL LTD.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 71. WILMAR INTERNATIONAL LTD.: REVENUE SHARE BY REGION, 2020 (%)

Companies Mentioned

• Archer Daniels Midland Company
• Bunge Ltd
• Cargill Inc.rporated
• DuPont de Nemours Inc
• Kewpie Corporation
• Lasenor Emul SL
• Lipoid GmbH
• SojaProtein a.d
• VAV Life Sciences Pvt. Ltd
• Wilmar International Ltd.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.